Company: RPTX
Filing Date: 2025-04-29
Form Type: DEFA14A
Source: 0001193125-25-103791
Chunk: 2

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEFA14A
Chunk 2
---
 To appoint Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025, and to authorize our board of directors to fix Ernst & Young LLP’s remuneration. NOTE: To conduct any other business properly brought before the Annual Meeting. For additional information, see “Proposal 1: Election of Directors”, “Proposal 2: Advisory Vote On Executive Compensation”, and “Proposal 3: Ratification of Selection of Independent Registered Public Accounting Firm” of the proxy statement for the 2025 Annual Meeting of Shareholders of Repare Therapeutics Inc.